MedPath

Klinikum Nürnberg

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:0
Completed:5

Trial Phases

2 Phases

Phase 2:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 2
1 (50.0%)

A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.

Phase 2
Recruiting
Conditions
Chronic Renal Failure
Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis
Chronic Kidney Disease Stage 3
Electrolyte and Fluid Balance Conditions
Interventions
Drug: Balcinrenone 50mg Capsule
Drug: Balcinrenone 50mg matching Placebo
Drug: Balcinrenone 100mg Capsule
Drug: Balcinrenone 100mg matching Placebo
First Posted Date
2023-06-01
Last Posted Date
2025-05-07
Lead Sponsor
Klinikum Nürnberg
Target Recruit Count
100
Registration Number
NCT05884866
Locations
🇫🇷

Assistance Publique-Hopitaux de Marseille (AP-HM), Marseille, France

🇩🇪

Klinikum Nuernberg, Nuremberg, Bavaria, Germany

Removal of Cytokines in Patients Undergoing Cardiac Surgery With CPB

Not Applicable
Conditions
Hemofiltration
Extracorporeal Circulation
First Posted Date
2017-04-07
Last Posted Date
2017-04-07
Lead Sponsor
Klinikum Nürnberg
Target Recruit Count
80
Registration Number
NCT03104179
Locations
🇩🇪

Klinikum Nürnberg - Nuremberg Hospital, Nuremberg, Bavaria, Germany

European Postgraduate Training in Geriatric Medicine

Conditions
Education
Geriatrics
First Posted Date
2015-03-04
Last Posted Date
2015-03-04
Lead Sponsor
Klinikum Nürnberg
Target Recruit Count
47
Registration Number
NCT02377908
Locations
🇩🇪

Insitute for Biomedicine of Aging, Nuremberg, Bavaria, Germany

Observational Trial of a Therapeutic Platelet Transfusion Regimen

Terminated
Conditions
Acute Myeloid Leukemia
Thrombocytopenia
First Posted Date
2014-10-28
Last Posted Date
2017-06-08
Lead Sponsor
Klinikum Nürnberg
Target Recruit Count
25
Registration Number
NCT02276651
Locations
🇩🇪

Klinikum Nurnberg, Nurnberg, Germany

Standardized Emergency Care for Community Acquired Pneumonia (CAP)

Completed
Conditions
Community Acquired Pneumonia
Pneumonia
Infection
First Posted Date
2013-10-16
Last Posted Date
2013-10-16
Lead Sponsor
Klinikum Nürnberg
Target Recruit Count
2819
Registration Number
NCT01963000
Locations
🇩🇪

City Hospital Nuremberg, Nuremberg, Bavaria, Germany

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.